RTW Biotech Opportunities Ltd
RTWFF
$1.66
-$0.09-5.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M |
| Total Revenue | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 14.89M | 14.89M | 2.66M | 2.66M | 1.44M |
| SG&A Expenses | 3.08M | 3.08M | 3.07M | 3.07M | 2.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.41M | 3.41M | 3.33M | 3.33M | 2.75M |
| Operating Income | 11.48M | 11.48M | -668.80K | -668.80K | -1.32M |
| Income Before Tax | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.37M | -20.37M | -25.82M | -25.82M | 42.91M |
| EBIT | 11.48M | 11.48M | -668.80K | -668.80K | -1.32M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.06 | -0.06 | -0.08 | -0.08 | 0.13 |
| Normalized Basic EPS | 0.01 | 0.01 | -0.02 | -0.02 | 0.06 |
| EPS Diluted | -0.06 | -0.06 | -0.08 | -0.08 | 0.13 |
| Normalized Diluted EPS | 0.01 | 0.01 | -0.02 | -0.02 | 0.06 |
| Average Basic Shares Outstanding | 330.06M | 330.06M | 335.71M | 335.71M | 335.71M |
| Average Diluted Shares Outstanding | 330.06M | 330.06M | 335.71M | 335.71M | 335.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |